Related by context. Frequent words. (Click for all words.) 76 Secondary endpoints included 76 Secondary endpoints include 73 secondary endpoints 69 secondary endpoint 66 composite endpoint 65 primary efficacy endpoint 65 primary efficacy endpoints 64 efficacy endpoints 64 IPSS 64 evaluable 63 primary endpoints 63 primary endpoint 63 bosentan 63 evaluable patients 63 cytogenetic response 63 annualized relapse 63 pharmacodynamic 62 mg BID 62 6R BH4 62 p = #.# [004] 62 clinical endpoints 62 placebo p = 62 P = .# 61 prespecified 61 QoL 61 HRQOL 61 PANSS 61 laboratory abnormalities 61 histologic 61 Pharmacokinetic 61 DAS# [002] 61 subscales 61 tiotropium 60 plus prednisone 60 demonstrated statistically significant 60 sinus rhythm 60 symptom severity 60 RECIST criteria 60 serum phosphorus 60 free survival PFS 60 tolerability 60 TYSABRI treated 60 mcg kg 60 plus methotrexate 59 dyspnea 59 statistically significant improvement 59 Endpoints 59 covariates 59 p = #.# [002] 59 FOLFIRI 59 creatinine clearance 59 renal function 59 candesartan 59 etanercept 59 FOLFOX 59 esomeprazole 59 subgroup analyzes 59 Postoperative 59 fasting plasma glucose 59 peginterferon alfa 2b 59 peg IFN 59 confidence interval CI 59 HbA1c levels 59 certolizumab pegol 59 preoperatively 59 vasomotor symptoms 58 noninferiority 58 prognostic factors 58 azacitidine 58 LVEF 58 comorbid conditions 58 placebo p 58 thromboembolic events 58 dacarbazine 58 nonresponders 58 fasting insulin 58 TELCYTA 58 ≥ 58 limiting toxicity 58 pharmacodynamics 58 febrile neutropenia 58 decitabine 58 sustained virologic response 58 Adverse events 58 RECIST 58 echocardiographic 58 hypomagnesemia 57 treatment emergent adverse 57 events AEs 57 ACTEMRA 57 glomerular filtration rate 57 ziprasidone 57 abciximab 57 neoadjuvant chemotherapy 57 p = 57 rotigotine 57 peginterferon 57 plus ribavirin 57 #mg dose [003] 57 PROMACTA 57 pharmacokinetics